Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction - PubMed (original) (raw)
Case Reports
. 2000 Jan 15;95(2):569-76.
Affiliations
- PMID: 10627464
Free article
Case Reports
Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction
G Kunz et al. Blood. 2000.
Free article
Abstract
Thrombomodulin is an endothelial cell receptor for thrombin. It functions as a natural anticoagulant by greatly accelerating activation of protein C by thrombin. Using a direct gene screening strategy we identified a frameshift insertion mutation, insT 1689, in the thrombomodulin gene of a patient with myocardial infarction. The mutation predicts an elongated gene product because of substitution of the 12 C-terminal amino acids by 61 abnormal residues. Pedigree analysis showed that the mutation was also likely to have been present in a sibling who had had fatal myocardial infarction. Carriers of the mutant allele express significantly lower amounts of thrombomodulin on the surface of their monocytes detected by flow cytometry and have lower levels of soluble thrombomodulin in plasma. Wild type and the mutant thrombomodulin were expressed in COS-7 cells. Cellular distribution of the expressed proteins was evaluated by immunofluorescence microscopy, which showed reduced cell surface expression and intense juxtanuclear localization of the abnormal protein. This suggests impaired translocation through the endoplasmic reticulum/Golgi apparatus. Cells expressing abnormal thrombomodulin had reduced ability ( approximately 2.5-fold) to accelerate the thrombin mediated activation of protein C. This is the first demonstration of reduced expression arising from a natural thrombomodulin gene mutation. The results provide support for the suggestion that gene mutation of thrombomodulin may be important in the pathogenesis of some cases of occlusive thrombotic disease. (Blood. 2000;95:569-576)
Similar articles
- A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men.
Doggen CJ, Kunz G, Rosendaal FR, Lane DA, Vos HL, Stubbs PJ, Manger Cats V, Ireland H. Doggen CJ, et al. Thromb Haemost. 1998 Nov;80(5):743-8. Thromb Haemost. 1998. PMID: 9843165 - Directed search for thrombomodulin gene mutations.
Ireland H, Kyriakoulis K, Kunz G, Lane DA. Ireland H, et al. Haemostasis. 1996 Oct;26 Suppl 4:227-32. doi: 10.1159/000217303. Haemostasis. 1996. PMID: 8979128 - Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
Li YH, Chen JH, Tsai WC, Chao TH, Guo HR, Tsai LM, Wu HL, Shi GY. Li YH, et al. Thromb Haemost. 2002 Jan;87(1):86-91. Thromb Haemost. 2002. PMID: 11848462 - Thrombomodulin gene variations and thromboembolic disease.
Ohlin AK, Norlund L, Marlar RA. Ohlin AK, et al. Thromb Haemost. 1997 Jul;78(1):396-400. Thromb Haemost. 1997. PMID: 9198186 Review. - Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis.
Anastasiou G, Gialeraki A, Merkouri E, Politou M, Travlou A. Anastasiou G, et al. Blood Coagul Fibrinolysis. 2012 Jan;23(1):1-10. doi: 10.1097/MBC.0b013e32834cb271. Blood Coagul Fibrinolysis. 2012. PMID: 22036808 Review.
Cited by
- Antiphospholipid syndrome: genetic review.
Namjou B. Namjou B. Curr Rheumatol Rep. 2003 Oct;5(5):391-4. doi: 10.1007/s11926-003-0030-8. Curr Rheumatol Rep. 2003. PMID: 12967526 Review. - Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM. Delvaeye M, et al. N Engl J Med. 2009 Jul 23;361(4):345-57. doi: 10.1056/NEJMoa0810739. N Engl J Med. 2009. PMID: 19625716 Free PMC article. - Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.
Tang Z, Tracy RP. Tang Z, et al. J Thromb Thrombolysis. 2001 Feb;11(1):49-81. doi: 10.1023/a:1008956327032. J Thromb Thrombolysis. 2001. PMID: 11248790 Review. No abstract available. - Thrombomodulin in patients with mild to moderate bleeding tendency.
Mehic D, Tolios A, Hofer S, Ay C, Haslacher H, Downes K, Haimel M, Pabinger I, Gebhart J. Mehic D, et al. Haemophilia. 2021 Nov;27(6):1028-1036. doi: 10.1111/hae.14433. Epub 2021 Oct 10. Haemophilia. 2021. PMID: 34628704 Free PMC article. - Thrombomodulin gene polymorphisms in brain infarction and mortality after stroke.
Olivot JM, Labreuche J, De Broucker T, Poirier O, Cambien F, Aiach M, Amarenco P; GENIC Investigators. Olivot JM, et al. J Neurol. 2008 Apr;255(4):514-9. doi: 10.1007/s00415-008-0725-x. Epub 2008 Jan 23. J Neurol. 2008. PMID: 18204921
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical